Reviva pharmaceuticals to participate in the 2022 bio international convention

Cupertino, calif.,, june 02, 2022 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), cardiovascular, metabolic, and inflammatory diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will participate in the 2022 bio international convention, to be held june 13-16 in san diego, ca. please see additional details below:
RVPH Ratings Summary
RVPH Quant Ranking